Alfuzosin HCl

FDA Drug Profile — Uroxatral

Drug Details

Generic Name
Alfuzosin HCl
Brand Names
Uroxatral
Application Number
NDA021287
Sponsor
Advanz Pharma (US) Corp.
NDC Codes
1
Dosage Forms
TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
ALFUZOSIN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE UROXATRAL is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. UROXATRAL is an alpha adrenergic antagonist, indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. ( 1 ) Important Limitations of Use: UROXATRAL is not indicated for treatment of hypertension. ( 1.1 ) UROXATRAL is not indicated for use in the pediatric population. ( 1.1 , 8.4 , 12.3 ) 1.1 Important Limitations of Use UROXATRAL is not indicated for the treatment of hypertension. UROXATRAL is not indicated for use in the pediatric population.